Dr. Shea is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 6th Ave S
Birmingham, AL 35233Phone+1 800-822-8816Fax+1 205-975-8394
Education & Training
Washington University in St. Louis School of MedicineClass of 2014
Certifications & Licensure
AL State Medical License 2016 - 2025
MO State Medical License 2018 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study) Start of enrollment: 2021 Dec 29
Roles: Contact, Principal Investigator
- Study of Tazemetostat in Lymphoid Malignancies Start of enrollment: 2024 Aug 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 9 citationsImpact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study.Narendranath Epperla, Rina Li Welkie, Pallawi Torka, Geoffrey Shouse, Reem Karmali
Journal of Hematology & Oncology. 2023-05-08 - 3 citationsCombined Kdm6a and Trp53 Deficiency Drives the Development of Squamous Cell Skin Cancer in Mice.Lauren K Shea, Neal S Akhave, Leslie A Sutton, Leigh A Compton, Conner York
The Journal of Investigative Dermatology. 2023-02-01 - 2 citationsPostibrutinib relapse outcomes for patients with marginal zone lymphoma.Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara K Moyo
Blood Advances. 2023-01-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
